Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator.

Arrhythm Electrophysiol Rev · 2019 · PMC6528055 · PMID 31114683

Europe PMC DOI

hedged sentences

0.0280

closest p · 0.6× alpha

0.0280

boldest claim

The sentences

marginally significantp=0.028actually significant

In a pre-specified secondary analysis, patients randomised to ranolazine had a marginally significant lower risk of ICD therapies for recurrent VT or VF (hazard ratio: 0.70; 95% confidence interval: 0.51–0.96; p=0.028).[ 21 ] See Table 2 for a summary of medical therapy studies.

also in 26,082 other papers

did not reach statistical significanceno p-value reported

While the results did not reach statistical significance, the study was underpowered based on pre-specified statistical criteria.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.